Destiny Pharma (DEST) Competitors

OptiBiotix Health (LON:OPTI) and Destiny Pharma (LON:DEST) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.

Does the media prefer OPTI or DEST?

In the previous week, Destiny Pharma had 2 more articles in the media than OptiBiotix Health. MarketBeat recorded 3 mentions for Destiny Pharma and 1 mentions for OptiBiotix Health. Destiny Pharma's average media sentiment score of 1.27 beat OptiBiotix Health's score of -0.21 indicating that OptiBiotix Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptiBiotix Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Destiny Pharma	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility & risk, OPTI or DEST?

OptiBiotix Health has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Comparatively, Destiny Pharma has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of OPTI or DEST?

6.3% of OptiBiotix Health shares are held by institutional investors. Comparatively, 25.6% of Destiny Pharma shares are held by institutional investors. 13.3% of OptiBiotix Health shares are held by insiders. Comparatively, 19.9% of Destiny Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts rate OPTI or DEST?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptiBiotix Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Destiny Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has stronger earnings and valuation, OPTI or DEST?

Destiny Pharma has lower revenue, but higher earnings than OptiBiotix Health. Destiny Pharma is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptiBiotix Health	£1.26M	12.85	-£13.18M	-£0.15	-118.33
Destiny Pharma	£135.03K	118.23	-£5.97M	-£0.08	-209.38

Is OPTI or DEST more profitable?

OptiBiotix Health's return on equity of -52.87% beat Destiny Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptiBiotix Health	N/A	-85.52%	-8.50%
Destiny Pharma	N/A	-52.87%	-36.69%

Does the MarketBeat Community prefer OPTI or DEST?

OptiBiotix Health received 70 more outperform votes than Destiny Pharma when rated by MarketBeat users. However, 60.48% of users gave Destiny Pharma an outperform vote while only 59.18% of users gave OptiBiotix Health an outperform vote.

Company	Underperform	Outperform
OptiBiotix Health	Outperform Votes 145 59.18%	Underperform Votes 100 40.82%
Destiny Pharma	Outperform Votes 75 60.48%	Underperform Votes 49 39.52%

Summary

Destiny Pharma beats OptiBiotix Health on 8 of the 14 factors compared between the two stocks.